These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 24792811

  • 1. Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity.
    Duan YT, Yao YF, Huang W, Makawana JA, Teraiya SB, Thumar NJ, Tang DJ, Tao XX, Wang ZC, Jiang AQ, Zhu HL.
    Bioorg Med Chem; 2014 Jun 01; 22(11):2947-54. PubMed ID: 24792811
    [Abstract] [Full Text] [Related]

  • 2. Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study.
    Wang R, Zhao X, Yu S, Chen Y, Cui H, Wu T, Hao C, Zhao D, Cheng M.
    Bioorg Chem; 2020 Sep 01; 102():104092. PubMed ID: 32707280
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents.
    Sun J, Yang YS, Li W, Zhang YB, Wang XL, Tang JF, Zhu HL.
    Bioorg Med Chem Lett; 2011 Oct 15; 21(20):6116-21. PubMed ID: 21889345
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents.
    Wang R, Chen Y, Zhao X, Yu S, Yang B, Wu T, Guo J, Hao C, Zhao D, Cheng M.
    Eur J Med Chem; 2019 Dec 01; 183():111716. PubMed ID: 31550660
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
    Zhang S, Luo Y, He LQ, Liu ZJ, Jiang AQ, Yang YH, Zhu HL.
    Bioorg Med Chem; 2013 Jul 01; 21(13):3723-9. PubMed ID: 23673215
    [Abstract] [Full Text] [Related]

  • 6. Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors.
    Sun J, Ren SZ, Lu XY, Li JJ, Shen FQ, Xu C, Zhu HL.
    Bioorg Med Chem; 2017 May 01; 25(9):2593-2600. PubMed ID: 28363444
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.
    Yang XH, Xiang L, Li X, Zhao TT, Zhang H, Zhou WP, Wang XM, Gong HB, Zhu HL.
    Bioorg Med Chem; 2012 May 01; 20(9):2789-95. PubMed ID: 22503364
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological evaluation of pyrazolyl-nitroimidazole derivatives as potential EGFR/HER-2 kinase inhibitors.
    Tao XX, Duan YT, Chen LW, Tang DJ, Yang MR, Wang PF, Xu C, Zhu HL.
    Bioorg Med Chem Lett; 2016 Jan 15; 26(2):677-683. PubMed ID: 26652482
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, biological evaluation and molecular docking studies of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives.
    Zhang LR, Liu ZJ, Zhang H, Sun J, Luo Y, Zhao TT, Gong HB, Zhu HL.
    Bioorg Med Chem; 2012 Jun 01; 20(11):3615-21. PubMed ID: 22541051
    [Abstract] [Full Text] [Related]

  • 13. Schiff's base derivatives bearing nitroimidazole and quinoline nuclei: new class of anticancer agents and potential EGFR tyrosine kinase inhibitors.
    Makawana JA, Sangani CB, Lin L, Zhu HL.
    Bioorg Med Chem Lett; 2014 Apr 01; 24(7):1734-6. PubMed ID: 24630412
    [Abstract] [Full Text] [Related]

  • 14. Identification of nitroimidazole-oxime derivatives targeting the polo-box domain of polo-like kinase 1.
    Sun J, Liu HY, Xu RF, Zhu HL.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6581-6588. PubMed ID: 29100732
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
    Lu L, Zhao TT, Liu TB, Sun WX, Xu C, Li DD, Zhu HL.
    Chem Pharm Bull (Tokyo); 2016 Nov 01; 64(11):1570-1575. PubMed ID: 27568484
    [Abstract] [Full Text] [Related]

  • 16. Structure-based modification of carbonyl-diphenylpyrimidines (Car-DPPYs) as a novel focal adhesion kinase (FAK) inhibitor against various stubborn cancer cells.
    Wang L, Ai M, Yu J, Jin L, Wang C, Liu Z, Shu X, Tang Z, Liu K, Luo H, Guan W, Sun X, Ma X.
    Eur J Med Chem; 2019 Jun 15; 172():154-162. PubMed ID: 30978560
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and biological evaluation of novel covalent inhibitors targeting focal adhesion kinase.
    Chen T, Liu Y, Shi M, Tang M, Si W, Yuan X, Wen Y, Chen L.
    Bioorg Med Chem Lett; 2021 Dec 15; 54():128433. PubMed ID: 34757216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.